|
Life Science in Austria
Interested in Austria as an investment destination?
Here’s another Atharva GloLife report
to make it easier for you!
Happy Investing! |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Canada
Canada’s position as a biotechnology leader—one of the top five countries in the world. Connect with Canada with a Atharva Lifesciences GloLife Report! |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Czech Republic
Lifesciences in the Czech Republic has become increasingly prominent over the past decade while bringing forth possible applications in a wide range of other, related sectors such as healthcare, agriculture and industry. Conscious of this development, the Czech Republic, through a Government Decree in 2005, set molecular genetics and biotechnologies among the priority areas in the long-term, fundamental direction of research.
Understand the Czech Repoblic, with an Atharva GloLife Report. |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Denmark
Denmark has the third-largest commercial
drug-development pipeline in Europe
in absolute numbers and is second in
Europe on the European Commission’s
Biotechnology Innovation Scoreboard.
Investment in Danish biotechnology has
reached more than EUR 3.8 billion — the
second largest in Europe. |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Finland
Finland is biotech country. Fish and forests
abound – apart from mobile phones!
The sector has evolved well because of
good government support and private
funding. Multiple biotech clusters are now
established in Finland. |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in France
France allocates 7% of its GDP to education, 9% to
healthcare and 2% to research. Over the last twenty
years, France has become a major player in the European
biotechnology sector. |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Greece
The Greek Life Sciences sector demonstrates a strong growth during the last decade. The report aims to inform about the sector’s growing prospects for investment and business development. |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Hungary
Hungary was the first country to produce vitamin B12 at
an industrial level. Discover Lifesciences in Hungary with and
Atharva GloLife report! |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in India
A large part of India’s attractiveness stems from the sheer size of its demographics. According to estimates 65 percent of the market is virtually untapped because the current infrastructure is good only to reach 30 to 35 percent of the population.
While the future looks bright, the challenges remain varied. From lack of clarity in terms of what is patentable, to infrastructure and policy issues, the journey to success is fraught with obstacles.
Understand India, With an Atharva GloLife report! |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Ireland
Ireland and science are almost synonymous with Ireland having a long history of science development and innovation.
Today, Ireland has over 170 bio – pharma companies employing 35,000 people in the in the pharmaceutical/ chemical, biopharmaceuticals, medical devices and diagnostics sectors and is the European home to such household names as Johnson & Johnson, Pfizer, Wyeth, Schering Plough, Bristol Meyers Squibb and Genzyme.
Explore Lifesciences in Ireland with an Atharva GloLife Report! |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Israel
Israel is home to a thriving Life Sciences
industry in which the major sectors are
Medical Devices and BioPharma. Over
the last 5 years,more companies were
established in life sciences than in any
other sector, with the rate of investments
(including Angels, Venture Capital and
Corporate) greatly outpacing all other
segments of the economy.
Explore lifesciences in Israel with an
Atharva Lifesciences report!
Shalom! |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Italy
Italian biotech companies are able to compete outstandingly on the international market, managing to grow despite continuing difficulties in the economic situation. With 394 companies, of which 248 pure biotech, Italy is third in Europe after Germany and the United Kingdom, for the number of pure biotech companies, with a strong growth trend. |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Malaysia
Malaysia aspires to be a biotechnology
hub and this is clearly spelled out in the
National Biotechnology Policy that was
launched on the 28th April 2005. It is estimated
that by 2020, this sector would
create 280,000 jobs and contribute five
per cent to the country’s Gross Domestic
Product.
Explore Lifesciences in Malaysia with a
Atharva GloLife Report! |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Mexico
The Mexican Economy Ministry estimates the domestic
market for products of biotechnological origin
to be approximately US$1 billion with strong growth
potential. Mexico has quietly been building up its biotechnology industry in recent years.
Mexico is a lifesciences oppurtunity. Understand
Mexico now with a Atharva GloLife Report! |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Netherlands
The Dutch ‘red’ biotech sector, is rising
higher in the international rankings of the
top clusters. A large number of companies
in the Netherlands are active in this sector
and the number of private investments by
venture capitalists are increasing.
The Netherlands is home to multiple partnerships
in biotechnology in which the
public and private sector work together
towards a bio-based economy by translating
knowledge into innovation. Public
parties work on disciplines like microbial
genomics, catalysis and process technology.
Understand the Dutch, with a Atharva
GloLife Report!
|
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in New Zealand
New Zealand has one of the fastest growing biotech industries the world. Apart from BioPharma,
New Zealand’s geographic isolation and strict quarantine standards contribute to the
best animal health rating in the world, uniquely positioning the country as a global leader
in agricultural biotechnology research and application. |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Russia
Russia is advancing rapidly. It recently successfully completed the first stage of clinical trials of an HIV vaccine. The State Research Center for Virology and Biotechnology, Vektor, completed the first stage of
clinical trials of the HIV vaccine.
Discover Lifesciences in Russia with a Atharva GloLife
report! |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in SMTP
|
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Spain
Spain has a long tradition of scientific excellence,
particularly in the life sciences.In the past decade
the country has focused on transforming its
research into consumer-focused companies and
products.
Understand Spain. With an Atharva GloLife Report! |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Sweden
Sweden has the fourth largest biotechnology industry
in Europe, after Germany, the UK
and France. Understand Lifesciences in Sweden with
an Atharva GloLife report! |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Taiwan
Taiwan is waking up to Biotechnology.In a new Biotechnology and New Pharmaceutical Development Act, companies can get a 35% tax exemption for investment in research and development into new drugs and high-end medical devices.As they become more economically developed,it is anticipated that China’s citizens will increase their spending on health and medicine, creating a biomedical and medical products industry boom. Taiwan can cash in on this. |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Thailand
Economically, reports show that Thailand will be the eighth largest economy in the Asia Pacific region by 2016. Real GDP growth is projected to increase in the forecast period, reaching 7.1% by 2016. Demographically, the EIU projects an annual growth rate of around 0.7% and the population to be the ninth largest in the Asia Pacific region by 2016. The elderly population is rising; Thailand is expected to have the eighth highest proportion in the Asia Pacific region. |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in Turkey
Turkey has been researching and investing
in biotechnology for almost four
decades. The term biotechnology first
appeared in the programs of the Scientific
and Technological Research Council
of Turkey (TÜBİTAK) in 1982. The State
Planning Organization (SPO) in 1988
defined biotechnology and the scientific
fields.
Discover Turkey with an Atharva GloLife
report! |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in U.S.A
In the quarter of a century since biotechnology
first became a commercial proposition,
the industry has gone through a
continuous ferment of change and reinvention.
Having started in the late 1970s
with fewer than a handful of companies,
the North American biotech business has
grown to a behemoth that consists of
more than 1,280 companies, with market
capitalization exceeding $200 billion. |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in United Arab Emirates
UAE is promoting its domestic pharmaceutical industry as a major emerging force in the Gulf and Arab markets. These efforts are likely to take the UAE ís domestic drugs industry to the next level, where it can compete with the foreign participants in the gulf and African region markets.
The pharmaceutical and Biotech market in the UAE was expected to reach more than $1 billion in 2009 end and will expand at a compound annual growth rate (CAGR)
of over 15% in next few years. |
|
 |
Price : $ 100/-
|
 |
|
|
|
Life Science in United Kingdom
The UK life sciences market is among the strongest and fastest-growing in the world. Biotechnology, healthcare and pharmaceutical industries in the UK have an outstanding track record in drug discovery, a strong academic base and increasing Government support for R&D through investment and tax credits. |
|
 |
Price : $ 100/-
|
 |
|
|